Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 9 Thyroid Neoplasms 3 Triple Negative Breast Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Endocrine Gland Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

Gemcitabine 5 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 selpercatinib 2 niraparib 2 napabucasin 2 entinostat 2 Ocoxin 2 Irinotecan 2 Bevacizumab 2 temsirolimus 1 tariquidar 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 irinotecan sucrosofate 1 ganitumab 1 copper dotatate CU-64 1 Valproic Acid 1 Trabectedin 1 Therapeutic Irrigation 1 Taxes 1 Sunitinib 1 Staining and Labeling 1 Sirolimus 1 Psilocybin 1 Phlebotomy 1 Paclitaxel 1 Oxaliplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endocrine Gland Neoplasms × Biopsy, Large-Core Needle × Clear all

NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Endocrine Gland Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡